Your browser doesn't support javascript.
loading
Is testicular microlithiasis a really innocent condition? its effects on oncological outcomes of germ cell testicular cancer: an observational study / ¿Son las microlitiasis testicular realmente un síntoma sin transcendencia? Sus efectos en los resultados oncológicos en el cáncer de testículo: estudio observacional
Selvi, Ismail; Sarikaya, Selcuk; Başar, Halil.
Afiliação
  • Selvi, Ismail; Karabük University Training and Research Hospital. Department of Urology. Karabük. Turkey
  • Sarikaya, Selcuk; Health Science University Gulhane Training and Research Hospital. Department of Urology. Ankara. Turkey
  • Başar, Halil; Health Science University Ankara Oncology Training and Research Hospital. Department of Urology. Ankara. Turkey
Arch. esp. urol. (Ed. impr.) ; 73(3): 215-229, abr. 2020. tab, graf
Artigo em Inglês | IBECS | ID: ibc-192919
Biblioteca responsável: ES1.1
Localização: BNCS
ABSTRACT

OBJECTIVES:

Although it is a well known condition that presence of testicular microlithiasis (TM) with the co-occurrence of specific risk factors such as history of previous germ cell testicular cancer (GCTC), infertility, undescended testes or atrophic testes have high risks for GCTC development,TM is still a controversial topic. Its effects on oncological outcomes have still not been investigated in detail. In this study, we aimed to evaluate whether the presence of TM has an effect on GCTC prognosis and oncological outcomes.

METHODS:

Seventy five patients among 93 patients who underwent radical orchidectomy between January 2010 and February 2016 were selected and divided into two groups. Group I consisted of 51 patients without TM. Group II consisted of 24 patients with TM. Each groups were compared in terms of demographic datas, prognostic risk factors, complete blood count parameters and oncological outcomes.

RESULTS:

During the median follow-up of 58 (1-106) months, a significantly higher local recurrence rate (54.2% vs. 3.9%, p < 0.001), distant metastasis rate (58.3% vs. 5.9%, p < 0.001) and lower cancer-spesific survival rate (45.8% vs. 94.1%, p < 0.001) were observed in patients with TM. In this group, the duration of recurrence-free survival (47.65±9.45 vs.101.96±2.80 months, p < 0.001), metastasis-free survival (49.50±8.88 vs. 100.00±3.36 months, p < 0.001) and cancer-specific survival (54.37±8.76 vs. 100.19±3.25 months, p < 0.001) were also statistically lower. In multivariate analysis, â-hCG, LDH, neutrophil/ lymphocyte ratio, monocyte/lymphocyte ratio and the presence of undescended testis were found as independent predictive factors for local recurrence, distant metastasis and cancer-specific survival. Red blood cell distribution width and the presence of testicular microlithiasis were found to be independent predictive factors for local recurrence.

CONCLUSION:

According to our results, bilateral TM was associated with higher rates of local recurrence, distant metastasis and cancer spesific mortality in presence of risk factors, regardless of classic or limited microlithiasis
RESUMEN

OBJETIVO:

Aunque es bien conocida la presencia de microlitiasis testiculares con el desarrollo de cáncer testicular, la infertilidad, teste no descendido o atrofia testicular, aun es un tema controvertido. Los efectos en los resultados oncológicos no han sido estudiados en detalle. En este estudio, nuestro objetivo ha sido evaluar la presencia de microlitiasis en los resultados oncológicos del cáncer de testículo.

MÉTODOS:

Un total de 75 pacientes fueron incluidosen el análisis de un total de 93 pacientes que recibieron una orquiectomía radical entre enero 2010 y febrero 2016. Los pacientes se dividieron en 2 grupos I- consta de 51 pacientes sin microlitiasis, II consta de 24 pacientes con microlitiasis. Ambos grupos fueron comparados en términos de variables demográficas, factores de riesgo, analítica sanguínea y resultados oncológicos.

RESULTADOS:

La mediana de seguimiento fue de 59 meses (1-106). Se observó un incremento significativo de la recurrencia local (54,2% vs. 3,9%, p < 0,001), metástasis a distancia (58,3% vs. 5,9%, p < 0,001) y bajada de la supervivencia cáncer especifica (45,8% vs. 94,1%, p < 0,001) en pacientes con microlitiasis. En este grupo, la duración de la superviviencia libre de recurrencia (47,65 ± 9,45 vs.101,96 ± 2,80 meses, p < 0,001), supervivencia libre de metástasis (49,50 ± 8,88 vs. 100,00 ± 3,36 meses, p < 0,001) y supervivencia cáncer especifica (54,37±8,76 vs.100,19 ±3, 25 meses, p < 0,001) fueron también menores. Al estudio multivariado, Beta-hCG, LDH, neutrophil/lymphocyte ratio, monocyte/lymphocyte y la presencia de testes no descendido fueron factores independientes predictores de recurrencia local, metástasis a distancia y supervivencia cáncer-especifica. La distribución de los hematíes y la presencia de microlitiasis fueron factores independientes de recurrencia local.

CONCLUSIONES:

Las microlitiasis bilaterales se asocian a mayor tasa de recurrencia local, metástasis a distancia y supervivencia cáncer especifica, independientemente de su tamaño
Assuntos
Buscar no Google
Coleções: Bases de dados nacionais / Espanha Base de dados: IBECS Assunto principal: Neoplasias Testiculares / Orquiectomia / Litíase / Recidiva Local de Neoplasia Limite: Adulto / Humanos / Masculino Idioma: Inglês Revista: Arch. esp. urol. (Ed. impr.) Ano de publicação: 2020 Tipo de documento: Artigo Instituição/País de afiliação: Health Science University Ankara Oncology Training and Research Hospital/Turkey / Health Science University Gulhane Training and Research Hospital/Turkey / Karabük University Training and Research Hospital/Turkey
Buscar no Google
Coleções: Bases de dados nacionais / Espanha Base de dados: IBECS Assunto principal: Neoplasias Testiculares / Orquiectomia / Litíase / Recidiva Local de Neoplasia Limite: Adulto / Humanos / Masculino Idioma: Inglês Revista: Arch. esp. urol. (Ed. impr.) Ano de publicação: 2020 Tipo de documento: Artigo Instituição/País de afiliação: Health Science University Ankara Oncology Training and Research Hospital/Turkey / Health Science University Gulhane Training and Research Hospital/Turkey / Karabük University Training and Research Hospital/Turkey
...